Featured Research

from universities, journals, and other organizations

New discovery in quest for better drugs

Date:
October 15, 2013
Source:
Monash University
Summary:
Scientists have combined cutting edge computer modelling with pharmacology and medicinal chemistry to reveal new insights into how the body interacts with novel drug treatments, in research that could lead to the creation of drugs that are more targeted and with fewer side effects.

Scientists have combined cutting edge computer modelling with pharmacology and medicinal chemistry to reveal new insights into how the body interacts with novel drug treatments, in research that could lead to the creation of drugs that are more targeted and with fewer side effects.

In a paper published today in Nature, researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) were part of an international team who investigated alternative drug recognition sites on G protein-coupled receptors (GPCRs) -- the largest and most important family of receptor proteins in the human body.

GPCRs play a role in virtually every biological process and most diseases, including neuropsychiatric disorders, cardiovascular disease, obesity and diabetes, inflammation and cancer. Almost half of all current medications available use GPCRs to achieve their therapeutic effect.

The new research into how GPCRs work at the molecular level has unlocked vital insights into how drugs interact with this therapeutically relevant receptor family.

Professor Arthur Christopoulos from MIPS said it was hoped the research would lead to the creation of drugs that are more targeted, and with fewer side effects.

"This study has cracked the secret of how a new class of drug molecule, which we have been studying for some time now, actually binds to a GPCR and changes the protein's structure to achieve its unique molecular effect," Professor Christopoulos said.

"This research can explain the behaviour of such drugs at the molecular level and facilitate structure-based design for new and more potent drugs."

By starting with a known crystal structure of a GPCR as a template, the team used computer simulations to map how different drugs and the receptor can "find" each other, and how they change their shape and orientation as they interact. Importantly, the predictions made by the computer simulations were validated by new biological experiments and by the rational design of a more potent molecule that targets the GPCR.


Story Source:

The above story is based on materials provided by Monash University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ron O. Dror, Hillary F. Green, Celine Valant, David W. Borhani, James R. Valcourt, Albert C. Pan, Daniel H. Arlow, Meritxell Canals, J. Robert Lane, Raphaλl Rahmani, Jonathan B. Baell, Patrick M. Sexton, Arthur Christopoulos, David E. Shaw. Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs. Nature, 2013; DOI: 10.1038/nature12595

Cite This Page:

Monash University. "New discovery in quest for better drugs." ScienceDaily. ScienceDaily, 15 October 2013. <www.sciencedaily.com/releases/2013/10/131015094657.htm>.
Monash University. (2013, October 15). New discovery in quest for better drugs. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2013/10/131015094657.htm
Monash University. "New discovery in quest for better drugs." ScienceDaily. www.sciencedaily.com/releases/2013/10/131015094657.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) — Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) — A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) — Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) — President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins